Decision of the EEA Joint Committee No 208/2024 of 23 September 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3059]
Date: 2024-09-23
Institutions: EEA Joint Committee
Subjects: European Economic Area, market approval, plant health control, plant health product, protein products, revision of an agreement




L_202403059EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2024/3059


19.12.2024







            DECISION OF THE EEA JOINT COMMITTEE No 208/2024
of 23 September 2024
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3059]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement.












(5)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32024 R 0821: Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 (OJ L, 2024/821, 11.3.2024),










—



32024 R 0839: Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 (OJ L, 2024/839, 11.3.2024),










—



32024 R 0835: Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 (OJ L, 2024/835, 13.3.2024),










—



32024 R 0836: Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 (OJ L, 2024/836, 13.3.2024).’














2.


The following points are inserted after point 13zzzzzzzzzzzzzzh (Commission Implementing Regulation (EU) 2023/2591):






‘13zzzzzzzzzzzzzzi.



32024 R 0821: Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/821, 11.3.2024).










13zzzzzzzzzzzzzzj.



32024 R 0839: Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/839, 11.3.2024).










13zzzzzzzzzzzzzzk.



32024 R 0835: Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/835, 13.3.2024).










13zzzzzzzzzzzzzzl.



32024 R 0836: Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/836, 13.3.2024).’










Article 2
The texts of Implementing Regulations (EU) 2024/821, (EU) 2024/839, (EU) 2024/835 and (EU) 2024/836 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 24 September 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 23 September 2024.


For the EEA Joint Committee


The President

Anders H. EIDE
            





(1)  
            OJ L, 2024/821, 11.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/821/oj.

(2)  
            OJ L, 2024/839, 11.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/839/oj.

(3)  
            OJ L, 2024/835, 13.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/835/oj.

(4)  
            OJ L, 2024/836, 13.3.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/836/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2024/3059/oj
ISSN 1977-0677 (electronic edition)